Literature DB >> 21281385

Persistence of nasolabial fold correction with a hyaluronic acid dermal filler with retreatment: results of an 18-month extension study.

Rhoda S Narins1, Fredric S Brandt, Steven H Dayan, Carl S Hornfeldt.   

Abstract

BACKGROUND: An 18-month persistence study reported nasolabial fold (NLF) improvements using a small gel-particle hyaluronic acid (SGP-HA) dermal filler lasted up to 18 months after one retreatment.
OBJECTIVE: [corrected] To evaluate the efficacy and persistence of SGP-HA for the correction of NLFs for up to 36 months. METHODS & MATERIALS: Subjects completing the 18-month persistence study were permitted to enroll in an 18-month extension trial. Most required second retreatments to achieve optimal correction of their NLFs. Subjects were followed for up to 36 months after their initial treatment. The primary efficacy measure was a 1-point improvement from baseline Wrinkle Severity Rating Scale (WSRS) score as determined by a blinded evaluator at different time points.
RESULTS: The study enrolled 52 subjects. Forty subjects required a second retreatment for optimum NLF correction. Mean retreatment volume was less than 50% of the initial treatment volume. Twenty-six subjects completed the study. Blinded assessments revealed that 94% to 100% of subjects maintained WSRS scores of 1 point or more higher than baseline throughout the study.
CONCLUSIONS: Participants in the 18-month extension of an 18-month SGP-HA persistence study continued to demonstrate improvement of NLFs up to 36 months after a second retreatment. The mean volume of SGP-HA required for optimum NLF correction decreased substantially with each retreatment. Subjects reported no treatment-related adverse events after the second retreatment.
© 2011 by the American Society for Dermatologic Surgery, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281385     DOI: 10.1111/j.1524-4725.2010.01863.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  5 in total

Review 1.  Clinical Applications of Hyaluronidase.

Authors:  Gregor Cornelius Weber; Bettina Alexandra Buhren; Holger Schrumpf; Johannes Wohlrab; Peter Arne Gerber
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

2.  Nasal Reshaping with Hyaluronic Acid: An Alternative or Complement to Surgery.

Authors:  Per Hedén
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-11-28

3.  Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase.

Authors:  Bettina Alexandra Buhren; Holger Schrumpf; Edwin Bölke; Kai Kammers; Peter Arne Gerber
Journal:  Eur J Med Res       Date:  2018-08-20       Impact factor: 2.175

4.  Repeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler.

Authors:  Hugues Cartier; Per Hedén; Henry Delmar; Per Bergentz; Cecilia Skoglund; Carolina Edwartz; Maria Norberg; Philippe Kestemont
Journal:  Dermatol Surg       Date:  2020-04       Impact factor: 2.914

5.  In vitro cultivation of canine multipotent mesenchymal stromal cells on collagen membranes treated with hyaluronic acid for cell therapy and tissue regeneration.

Authors:  T I Wodewotzky; J F Lima-Neto; O C M Pereira-Júnior; M J Sudano; S A F Lima; P R O Bersano; S A Yoshioka; F C Landim-Alvarenga
Journal:  Braz J Med Biol Res       Date:  2012-09-18       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.